Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02392910Phase 4Completed
Phase 4, randomised, double-blind trial of iron sucrose in iron deficiency anemia (IDA) and anemia, sponsored by Hospital Alemán. Primary endpoint: All-cause Mortality at 5 years. Started Mar 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02392910.